Literature DB >> 16890287

RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia.

Sara Rollinson1, Alexandra G Smith, James M Allan, Peter J Adamson, Kathryn Scott, Christine F Skibola, Martyn T Smith, Gareth J Morgan.   

Abstract

Homologous recombination (HR) is one of the main pathways for the repair of DNA double strand breaks (DSBs). To investigate whether inherited variants in genes encoding proteins that repair DSBs by HR modulate acute myeloid leukaemia (AML) risk, we have examined the frequency of two variants in the 5' untranslated region (UTR) of RAD51 (RAD51 135 G>C and the RAD51 172 G>T) in a large case-control study of acute myeloid leukaemia (AML). Inheritance of a RAD51 135 C allele was associated with a reduced risk of estimate for AML (odds ratio (OR) 0.56, 95% confidence intervals (CI), 0.38-0.83), while the RAD51 172 T allele was not associated with AML. The RAD51 135 and 172 variants were in strong linkage disequilibrium, with three out of the four possible haplotypes being observed in the population. The protective effect associated with the RAD51 135 C allele was found to be associated with inheritance of the RAD51 135-172 C-G haplotype (cases 3.9% versus controls 6.5%, OR 0.61, 95% CI 0.42-0.90). These data suggest that variants in the RAD51 HR gene may modulate genetic predisposition to AML.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890287     DOI: 10.1016/j.leukres.2006.05.028

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

1.  Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.

Authors:  Bei-Bei Zhang; Dao-Gang Wang; Chao Xuan; Gui-Li Sun; Kai-Feng Deng
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

2.  ARLTS1, MDM2 and RAD51 gene variations are associated with familial breast cancer.

Authors:  Elif Akisik; Hulya Yazici; Nejat Dalay
Journal:  Mol Biol Rep       Date:  2010-04-01       Impact factor: 2.316

3.  Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis.

Authors:  Ya-zhou He; Xin Hu; Xiao-sa Chi; Yuan-chuan Zhang; Xiang-Bing Deng; Ming-tian Wei; Zi-qiang Wang; Yan-hong Zhou
Journal:  Tumour Biol       Date:  2013-08-17

4.  Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity.

Authors:  Qing Lan; Luoping Zhang; Min Shen; William J Jo; Roel Vermeulen; Guilan Li; Christopher Vulpe; Sophia Lim; Xuefeng Ren; Stephen M Rappaport; Sonja I Berndt; Meredith Yeager; Jeff Yuenger; Richard B Hayes; Martha Linet; Songnian Yin; Stephen Chanock; Martyn T Smith; Nathaniel Rothman
Journal:  Carcinogenesis       Date:  2008-10-31       Impact factor: 4.944

5.  Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.

Authors:  Wei Wang; Jia-Lin Li; Xiao-Feng He; An-Ping Li; Yong-Lin Cai; Na Xu; Shu-Mei Sun; Bing-Yi Wu
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

6.  RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis.

Authors:  Dan Cheng; Huimin Shi; Kan Zhang; Lingling Yi; Guohua Zhen
Journal:  Diagn Pathol       Date:  2014-01-23       Impact factor: 2.644

7.  Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia.

Authors:  Claudia Bănescu; Adrian P Trifa; Smaranda Demian; Erzsebeth Benedek Lazar; Delia Dima; Carmen Duicu; Minodora Dobreanu
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

Review 8.  Association between RAD51 135 G/C polymorphism and risk of 3 common gynecological cancers: A meta-analysis.

Authors:  Xianling Zeng; Yafei Zhang; Lei Yang; Huiqiu Xu; Taohong Zhang; Ruifang An; Kexiu Zhu
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  Polymorphisms of homologous recombination RAD51, RAD51B, XRCC2, and XRCC3 genes and the risk of prostate cancer.

Authors:  Maria Nowacka-Zawisza; Ewelina Wiśnik; Andrzej Wasilewski; Milena Skowrońska; Ewa Forma; Magdalena Bryś; Waldemar Różański; Wanda M Krajewska
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-03       Impact factor: 2.916

10.  Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies.

Authors:  Mengmeng Zhao; Pin Chen; Yanbin Dong; Xianji Zhu; Xilong Zhang
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.